A Review on Graph Neural Networks for Predicting Synergistic Drug Combinations

Author:

Besharatifard Milad1,Vafaee Fatemeh1

Affiliation:

1. University of New South Wales (UNSW)

Abstract

Abstract Combinational therapies with synergistic effects provide a powerful treatment strategy for tackling complex diseases, particularly malignancies. Discovering these synergistic combinations, often involving various compounds and structures, necessitates exploring a vast array of compound pairings. However, practical constraints such as cost, feasibility, and complexity hinder exhaustive in vivo and in vitro experimentation. In recent years, machine learning methods have made significant inroads in pharmacology. Among these, Graph Neural Networks (GNNs) have gained increasing attention in drug discovery due to their ability to represent complex molecular structures as networks, capture vital structural information, and seamlessly handle diverse data types. This review aims to provide a comprehensive overview of various GNN models developed for predicting effective drug combinations, examining the limitations and strengths of different models, and comparing their predictive performance. Additionally, we discuss the databases used for drug synergism prediction and the extraction of drug-related information as predictive features. By summarizing the state-of-the-art GNN-driven drug combination prediction, this review aims to offer valuable insights into the promising field of computational pharmacotherapy.

Publisher

Research Square Platform LLC

Reference97 articles.

1. Drug combinations in breast cancer therapy;Fisusi FA;Pharm Nanatechnol,2019

2. Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer;Molina-Arcas M;Sci Transl Med,2019

3. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer;Lui GY;EBioMedicine,2020

4. Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action;Azad A;Patterns,2021

5. Gilvary C, Dry JR, Elemento O (2019) Multi-task learning predicts drug combination synergy in cells and in the clinic. BioRxiv, : p. 576017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3